ARCHIVES

Prognostic Factors Don’t Explain Better Prostate Cancer Survival In Most Asian Men

This article is from The Cancer Letter archive.

Vol. 30 No. 8 | August 31, 2007

Download PDF Visit The Full Archive

Related Articles

NCI And SPORE PIs Discussing Potential Changes To Grant Program Guidelines.

September 19, 2008

NCI’s Justification For 1981 Budget

June 8, 1979

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay

March 28, 1980

Health Organizations Endorse “Patients’ Rights” Document

November 17, 1995